The SURMOUNT trials showed tirzepatide at 15 mg producing over 22% body weight loss on average, compared to roughly 15% for semaglutide 2.4 mg in the STEP trials
Astrup A, Carraro R, Finer N, Harper A, Kunesova M, Lean ME, Niskanen L, Rasmussen MF, Rissanen A, Rossner S, Savolainen MJ, Van Gaal L, Investigators NN (2012) Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
Initial consultations help tailor the treatment to your specific health goals
It works best when combined with clinical monitoring, nutrition support, strength-focused habits and long-term planning
The site is also packed with helpful information and content, from dosing information to chemical registry numbers, even molecular weights, and anything you cant find, support agents can help with
Therefore, there are limited clinical trial data with semaglutide use in pregnant women. While evidence in humans is lacking, animal studies have suggested semaglutide can cause foetal abnormalities
